Partnership for productive development of biosimilar products: perspectives of access to biological products in the Brazilian market.
Scheinberg, Morton Aaron; Felix, Paulo Antonio Oldani; Kos, Igor Age; Andrade, Maurício De Angelo; Azevedo, Valderilio Feijó.
Einstein (Sao Paulo)
; 16(3): eRW4175, 2018 Sep 17.
Artigo em Inglês, Português | MEDLINE | ID: mdl-30231147
The use of biosimilar medicines in oncology - position statement of the Brazilian Society of Clinical Oncology (SBOC)
Recommendations on how to ensure the safety and effectiveness of biosimilars in Latin America: a point of view.
Biosimilar: what it is not.
Billigare med biosimilarer - men säkerheten går först.
The changing landscape of biosimilars in rheumatology.
The process defines the product: what really matters in biosimilar design and production?
Biosimilars: where we were and where we are.
Bioanalytical strategy used in development of pharmacokinetic (PK) methods that support biosimilar programs.
Biosimilars take center stage.
Competition in the Age of Biosimilars.